Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 17 studies | 30% ± 11% | |
fibroblast | 10 studies | 25% ± 7% | |
oligodendrocyte | 6 studies | 26% ± 8% | |
interneuron | 4 studies | 42% ± 21% | |
GABAergic neuron | 4 studies | 24% ± 9% | |
endothelial cell of lymphatic vessel | 4 studies | 28% ± 7% | |
astrocyte | 3 studies | 30% ± 14% | |
vein endothelial cell | 3 studies | 28% ± 12% | |
connective tissue cell | 3 studies | 21% ± 2% | |
myofibroblast cell | 3 studies | 27% ± 13% | |
smooth muscle cell | 3 studies | 21% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 27% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2725.54 | 651 / 653 | 86% | 3.62 | 519 / 605 |
breast | 100% | 2452.82 | 459 / 459 | 66% | 2.06 | 736 / 1118 |
lung | 100% | 3796.29 | 578 / 578 | 65% | 2.41 | 750 / 1155 |
prostate | 92% | 1636.08 | 225 / 245 | 66% | 1.82 | 330 / 502 |
intestine | 93% | 3538.11 | 902 / 966 | 58% | 1.60 | 306 / 527 |
stomach | 81% | 1341.75 | 291 / 359 | 70% | 2.71 | 199 / 286 |
esophagus | 84% | 2363.84 | 1220 / 1445 | 62% | 1.95 | 114 / 183 |
kidney | 69% | 823.29 | 61 / 89 | 78% | 4.73 | 704 / 901 |
bladder | 100% | 2070.86 | 21 / 21 | 35% | 1.01 | 175 / 504 |
uterus | 99% | 1935.93 | 168 / 170 | 28% | 1.49 | 128 / 459 |
ovary | 99% | 2140.26 | 178 / 180 | 26% | 0.47 | 112 / 430 |
skin | 84% | 3087.26 | 1516 / 1809 | 25% | 0.68 | 118 / 472 |
brain | 28% | 221.26 | 744 / 2642 | 73% | 2.07 | 512 / 705 |
blood vessel | 100% | 5365.06 | 1335 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 2623.69 | 1202 / 1204 | 0% | 0 | 0 / 0 |
spleen | 98% | 1542.88 | 235 / 241 | 0% | 0 | 0 / 0 |
heart | 95% | 1780.87 | 815 / 861 | 0% | 0 | 0 / 0 |
liver | 54% | 400.19 | 121 / 226 | 32% | 0.62 | 130 / 406 |
pancreas | 12% | 83.71 | 38 / 328 | 71% | 2.21 | 126 / 178 |
adrenal gland | 52% | 403.93 | 134 / 258 | 29% | 0.64 | 67 / 230 |
muscle | 46% | 382.39 | 367 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 29% | 0.99 | 13 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0021987 | Biological process | cerebral cortex development |
GO_0022008 | Biological process | neurogenesis |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0007157 | Biological process | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
GO_0035329 | Biological process | hippo signaling |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FAT4 |
Protein name | FAT atypical cadherin 4 Protocadherin FAT4 Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J) |
Synonyms | Nbla00548 CDHF14 FATJ |
Description | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. FAT4 plays a role in the maintenance of planar cell polarity as well as in inhibition of YAP1-mediated neuroprogenitor cell proliferation and differentiation (By similarity). . |
Accessions | X2G0E6 X2G0F0 X2G254 ENST00000394329.9 A0A7P0T1I0 X2G5I7 A0A6Q8JR05 X2G248 ENST00000335110.5 [Q6V0I7-2] X2G756 X2GA64 X2GA70 Q6V0I7 ENST00000674496.2 |